Literature DB >> 3298417

Hepatic clearance and liver blood flow.

S Keiding.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3298417     DOI: 10.1016/s0168-8278(87)80552-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  14 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 2.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 3.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

Review 4.  Dose adjustment in patients with liver disease.

Authors:  Fabiola Delcò; Lydia Tchambaz; Raymond Schlienger; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery?

Authors:  Andrea De Gasperi; Ernestina Mazza; Manlio Prosperi
Journal:  World J Hepatol       Date:  2016-03-08

6.  Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.

Authors:  C Merkel; M Bolognesi; P Angeli; G F Finucci; P Amodio; S Bellon; A Gatta
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 7.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

Review 8.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

9.  Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.

Authors:  C Merkel; A Gatta; M Zoli; M Bolognesi; P Angeli; T Iervese; G Marchesini; A Ruol
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

10.  Combined evaluation of total and functional liver plasma flows and intrahepatic shunting.

Authors:  G Molino; P Avagnina; M Ballarè; M Torchio; A G Niro; P E Aurucci; M Grosso; C Fava
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.